Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma

OBJECTIVE: More effective regimens for advanced esophageal squamous cell carcinoma (ESCC) are urgently needed. Therefore, a retrospective study concerning the efficacy and safety of nanoparticle albumin-bound paclitaxel plus cisplatin (nab-TP) versus solvent-based paclitaxel plus cisplatin (sb-TP) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hai-ying, Yao, Zhi-hua, Tang, Hong, Zhao, Yan, Zhang, Xiao-san, Yao, Shu-na, Yang, Shu-jun, Liu, Yan-yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045233/
https://www.ncbi.nlm.nih.gov/pubmed/27713635
http://dx.doi.org/10.2147/OTT.S108580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045233/
https://www.ncbi.nlm.nih.gov/pubmed/27713635
http://dx.doi.org/10.2147/OTT.S108580

Ejemplares similares